{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-020883","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.874712+00:00","generated_at":"2026-06-01T10:48:40.978209+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Processa enters ATM equity agreement to sell up to $2.4M in common stock","bullets":["Sales agreement with A.G.P./Alliance Global Partners for at-the-market offering of up to $2.4 million.","Sales Agent receives up to 3% commission on gross proceeds from shares sold.","Net proceeds to fund R&D for oncology drug candidates and working capital.","Registration statement filed on May 21, 2024 but not yet effective.","Company is not obligated to sell any shares under the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-020883","json":"https://secwatch.observer/filing/0001493152-24-020883.json","markdown":"https://secwatch.observer/filing/0001493152-24-020883.md","text":"https://secwatch.observer/filing/0001493152-24-020883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/0001493152-24-020883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:48:40.978209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}